Investment analysts at HC Wainwright raised their Q1 2025 EPS estimates for ArriVent BioPharma in a report issued on Wednesday, January 22nd. HC Wainwright analyst R. Burns now anticipates that the ...
We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look ...
GLJ Research lowered its price target on JinkoSolar Holding Co., Ltd. (NYSE:JKS) to $10.95 from $13.08, while maintaining a Sell rating. The firm cited concerns over potential tariffs from the Trump ...
Q4 2024 Earnings Call Transcript January 22, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.04, ...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
KOCHI: In a major operation to disrupt the distribution of narcotic substances, over 500 sacks of banned tobacco products, ...
The company's multiple myeloma franchise, which includes Carvykti, stands to contribute significantly to its growth in 2025.
Israel says it will maintain control of the Rafah border crossing between Egypt and the Gaza Strip during the first phase of ...
Keros Therapeutics (KROS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price ...
Johnson & Johnson (NYSE:JNJ) reported a fourth-quarter adjusted EPS of $2.04, down 10.9% year over year, beating the ...
In this article, we will take a look into The Goldman Sachs Group Inc's (NYSE:GS) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash ...
Enid Public Schools Board of Education members approved a one-year extension of Superintendent Dudley Darrow’s three-year ...